Below is the final list of Abstracts received for Focus 2003. If your abstract does not appear on this page and you think it should, it is your responsibility to contact the Focus Office.
Appearance on this list does not guarantee acceptance; authors will be notified whether their abstracts have been accepted by 7th March 2003.
| Dr M Adrees |
|
Mild renal impairment assessed by serum cystatin C in subclinical hypothyrodism |
|
| Dr M V Ahmed |
|
A simple and sensitive method for the determination of cyanide in whole blood using headspace gas chromatography with electron capture detection |
|
| Dr M V Ahmed |
|
Comparison of serum PTH concentration measured using the Nichols AdvantageR Intact and Nichols AdvantageR Biointact assay kits |
|
| Mrs R Ajmal-Ali |
|
Acromegaly presenting as PCOS |
|
| Prof A O Akanji |
|
APOE polymorphism and lipoprotein levels in a Gulf Arab population |
|
| Mr K R Allen |
|
Micronutrient concentrations in patients receiving long term parenteral nutrition |
|
| Mr K R Allen |
|
Micronutrient concentrations in patients with cancer-effect of the inflammatory response |
|
| Mr N R Anderson |
|
Is measurement intact parathyroid hormone a useful screen for vitamin D deficiency? |
|
| Ms P Angel |
|
Point-of-care testing for urine HCG: an audit of North Thames activity |
|
| Ms Z Arkir |
|
The case of the lost urate |
|
| Ms Z Arkir |
|
Preliminary evaluation of IDS OCTEIA 25-Hydroxy Vitamin D kit |
|
| Dr A E Armston |
|
'The worst case I have ever observed': an 11-month-old boy with severe eczema presenting with hyponatraemia due to severe malnutrition |
|
| Dr A E Armston |
|
Wessex chemical pathology audit on the interpretation of serum cortisol levels |
|
| Dr L M Bailey |
|
Comparison of three assays for the measurement of 25-hydroxycalciferol in patients with metabolic bone disease |
|
| Miss K L Bainbridge |
|
Investigation of circulating cardiac troponin in serum following myocardial damage |
|
| Miss K L Bainbridge |
|
Analytical evaluation of the Access AccuTnI cardiac troponin I immunoassay |
|
| Dr E J Barrett |
|
Management of issues associated with the transfer of Abbott CA15-3, CA19-9 and CA125 tumour marker assays to the Immulite 2000 system |
|
| Mrs W E Bennitt |
|
MHRA evaluation of three neonatal bilirubinometers |
|
| Ms S Bex |
|
Complementing the patient with recurrent infections |
|
| Dr S A Bowles |
|
Fibrate-induced hypoalphalipoproteinaemia |
|
| Ms Ann Bowron |
|
The addition of 3-deazaadenosine to vacutainer tubes stabilises whole blood homocysteine for at least 6 hours at ambient temperature |
|
| Mrs V A Bradley |
|
Audit of detection thresholds for cerebrospinal fluid xanthochromia by naked eye compared to spectrophotometry |
|
| Mr T Branch |
|
A database designed to support the management of laboratory staff |
|
| Dr K Brent |
|
Is procalcitonin a discriminant diagnostic marker of invasive bacterial infection in children presenting to acute services? |
|
| Dr D G Bullock |
|
Matrix effects in EQA specimens |
|
| Dr S Bulusu |
|
A cautionary tale about the importance of accurate assessment and management of hyperparathyroidism |
|
| Dr J A Burrows |
|
Determination of thiopurine s-methyltransferase activity by capillary electrophoresis |
|
| Dr J A Burrows |
|
Macroprolactin and the Tosoh AIA-21 prolactin assay: detection by precipiation with polyethylene glycol and determination of monomeric prolactin |
|
| Mrs C A Burtonwood |
|
Evaluation of drugs of abuse test devices by the Medicines and Healthcare Products Regulatory Agency |
|
| Dr J Calvin |
|
Six cases of cystic fibrosis wth neonatal hypertrypsinaemia and normal or equivocal sweat test results |
|
| Dr J Calvin |
|
Raised immunoreactive trypsin in metabolic disease other than cystic fibrosis |
|
| Ms S A Carey |
|
Audit as a tool to improve accuracy of PID entry |
|
| Dr R S Carling |
|
Diagnosis of carcinoid disease: which test is best? |
|
| Dr C Chaloner |
|
Biochemical monitoring for children receiving parenteral nutrition, Part I: urea, electrolytes, liver function tests, chloride and bicarbonate |
|
| Mr B Y Chan |
|
Use of C-terminal telopeptides as a marker of recombinant RANKL-generated osteoclast resorptive activity on dentine wafers |
|
| Miss D j Chantler |
|
Audit of thyroid function tests 2001: incidence and detection of secondary hypothyroidism |
|
| Dr R Chetty |
|
Serum uric acid correlates with the 2-hour plasma glucose but not with fasting glucose |
|
| Dr R Chetty |
|
The renal clearances of water and electrolytes after maximal water diuresis and post frusemide in the diagnosis of Gitelman's Syndrome |
|
| Mr John Christofides |
|
Measurement of urinary metadrenalines by the new Chromsystems HPLC kit will improve specificity and save sample preparation time |
|
| Dr P M Clark |
|
Inconsistencies in the measurement of serum/plasma insulin |
|
| Dr W Collins |
|
Evaluation of the Roche E170 analyser for a routine clinical service |
|
| Mrs C M Corns |
|
Herbal therapy and clinical biochemistry |
|
| Mrs C M Corns |
|
Hypothyroidism in dragons |
|
| Mrs L M Cranfield |
|
North Thames regional audit of haematinic performance by laboratories
|
|
| Mr A P Cudmore |
|
The final bottleneck: data entry congestion charges resolved by request form scanner |
|
| Mr C F Cusick |
|
Congenital hypothyroid screening: the effect of changing collection date and TSH cut-off on age at treatment |
|
| Mr P Das |
|
CRP: causing real problems |
|
| Dr E M Davidson |
|
Point of care microalbuminuria testing: reduction in laboratory request numbers |
|
| Dr E M Davidson |
|
Point of care test results are important in the interpretation of laboratory data |
|
| Dr K A Deans |
|
Asymptomatic hypoglycaemia in continuous glucose monitoring |
|
| Miss J Donovan |
|
Neurohormonal activation in patients with congenital heart disease |
|
| Dr A C Don-Wauchope |
|
Acute pancreatitis prognostic score in practice |
|
| Dr A C Don-Wauchope |
|
Clinical features of patients with macroprolactinaemia |
|
| Ms L J Downey |
|
The interference of triglycerides on paracetamol measurement |
|
| Mr A R Ellis |
|
UK NEQAS for LH: interference by hCG - possible diagnostic confusion? |
|
| Mr A S Everitt |
|
Validation of Olympus bromocresol green albumin method for use with samples from patients with renal disease on haemodialysis |
|
| Mrs C Fahm |
|
A relational database for communications management |
|
| Prof G Ferns |
|
Trace element status in metabolic syndrome and obesity |
|
| Dr A M Fielding |
|
Alternative approaches to the detection of macroprolactinaemia |
|
| Dr R A Fisher |
|
A case of non-virilising adrenocortical adenoma co-secreting testosterone and cortisol in a woman with long-standing hirsutism |
|
| Dr Chris Florkowski |
|
Elevated urine trace element output following acute volcanic gas exposure at White Island, New Zealand |
|
| Dr Chris Florkowski |
|
Abbott Axsym Troponin I and Roche Elecsys Troponin T show comparable diagnostic accuracy for myocardial infarction |
|
| Dr C Ford |
|
A case of paediatric iron deficiency anaemia resistant to treatment with oral iron |
|
| Dr L Ford |
|
Can conventional dried blood spots be used for vitamin A and E determination? |
|
| Ms J M Forsyth |
|
Wanted: a commercial BCP reagent that accurately measures albumin in serum and plasma |
|
| Dr G M Frederick |
|
Are we able to comply with CPA standard E6 (referral of work to other laboratories)? |
|
| Dr S Fredericks |
|
Elevated serum neopterin predicts major adverse coronary events in smokers with chronic stable angina |
|
| Dr S Fredericks |
|
Plasma protein-Z deficiency is a risk factor for coronary artery disease |
|
| Miss J A French |
|
Factors that affect the consensus means for LDL cholesterol in the UK NEQAS for Lipid Investigations |
|
| Dr S J Frost |
|
An audit of oral glucose tolerance test requests |
|
| Dr D Gaffney |
|
An improved choice of primers for diagnosis or exclusion of genetic haemochromatosis using DNA from post mortem tissue |
|
| Dr K S Gan |
|
Development of non-radioactive methods for the detection of AGXT intron 4 VNTR and their application to linkage analysis of primary hyperoxaluria type 1 |
|
| Mrs L Garrison |
|
Evaluation of high-sensitivity CRP analyses on three automated platforms |
|
| Mrs L Garrison |
|
CSF scanning for xanthochromia: impact of new guidelines on predicting patient outcomes |
|
| Dr A E Gbegbaje |
|
Preliminary study of intestinal permeability in the assessment of gastrointestinal symptoms in patients with autism spectrum disorders |
|
| Dr R G Gray |
|
Quantitation of urinary glycosaminoglycans using dimethylene blue for detection of the mucopolysaccharidoses: an evaluation |
|
| Miss J Greenwood |
|
The role of hyaluronic acid as a marker of liver viability in non-heart beating donor porcine livers |
|
| Mr M Gunter |
|
Introduction of Biorad Variant 2 HPLC analyser for measurement of HbA1c in clinical research |
|
| Dr A Haddon |
|
The impact of weight loss on improvement of metabolic risk factors |
|
| Dr D J Halsall |
|
Genotype-phenotype correlation in families with C1 inhibitor deficiency and hereditary angiodema |
|
| Dr D J Halsall |
|
Application of linear dichroism to real-time PCR |
|
| Miss B E Harland |
|
The use of gender-specific reference intervals are appropriate in the interpretation of urine total metadrenalines |
|
| Dr A J Hartland |
|
A rare case of dense ocular deposition associated with IgG monoclonal gammopathy and hypercupraemia |
|
| Dr A M Hassan |
|
Empty sella, full uterus |
|
| Dr A M Hassan |
|
Assessment of lipid-profile service in North-West and Mersey regions of England |
|
| Dr F Hemraj |
|
Evaluation of a fluoresence quenching method of serum fructosamine assay |
|
| Dr F Hemraj |
|
Detection of incipient nephropathy in Mauritian diabetics: which strategy? |
|
| Dr F Hemraj |
|
Home blood glucose monitoring: how useful can it be for the Mauritian diabetic? |
|
| Dr F Hemraj |
|
Can creative protein be used as sole indicator for neonatal sepsis? |
|
| Dr F Hemraj |
|
Type 2 diabetes: do haemoglobin variants interfere with glycaemic indicators in Mauritian diabetics? |
|
| Dr F Hemraj |
|
Evaluation of a fluorimetric method to assay serum fructosamine in Mauritian diabetics |
|
| Dr M J Henderson |
|
Total leukocyte cystine measurement, European Quality Assurance Initiative |
|
| Mr A D Heys |
|
Low insulin results by Abbott Axsym assay in a case of insulinoma |
|
| Mr G J Higgins |
|
Haemoglobinopathies incidence in a Merseyside, UK, diabetic population and effect on HbA1c assay with Menarini HA-8140 analyser |
|
| Dr P G Hill |
|
IgA antibodies to human tissue transglutaminase: a first line test for coeliac disease |
|
| Dr P G Hill |
|
13C-triolein as a marker substrate for fat absorption in humans |
|
| Dr T Hitch |
|
Doing things together: an audit of B12 and folate results after the merger of a clinical chemistry and haematology department |
|
| Miss S L Hogg |
|
Classical homocystinuria presenting as pregnancy-associated osteoporosis |
|
| Miss S L Hogg |
|
Undiagnosed maternal phenylketonuria presenting as X-linked mental retardation |
|
| Dr H C Holmes |
|
Evaluation of the Nichols AdvantageR immunoassay for plasma aldosterone |
|
| Dr H C Holmes |
|
Evaluation of the direct renin assay on Nichols AdvantageR: how well can it detect low and suppressed plasma renin activity? |
|
| Dr J W Honour |
|
Spironolactone interference in the immunoassay of androstenedione |
|
| Dr J W Honour |
|
Recognition of Smith Lemli Opitz syndrome by urine steroid profile analysis |
|
| Dr S M Hughes |
|
Could procalcitonin be a valid point-of-care test for invasive bacterial infection in children presenting to primary or secondary care? |
|
| Dr S M Hughes |
|
Is procalcitonin the preferred marker of invasive bacterial disease in the early presentation of potentially serious infection? |
|
| Mrs U Huibers Gibbons |
|
An unusual case of hypertension |
|
| Miss C Humphries |
|
An audit of biochemistry incident reporting |
|
| Miss C Humphries |
|
Perimenopausal hyperthecosis: a distinct pathological entity associated with marked hyperandrogenaemia |
|
| Dr F M Ivison |
|
Concordance of results for two methods of calculating free testosterone concentration: are the results valid? |
|
| Mrs N F Jassam |
|
Validation of PEG as a pre-analytical step for immunoassay of AFP, FSH and prolactin |
|
| Mrs M A Jenkins |
|
Ten years use of capillary electrophoresis |
|
| Dr F Jenkinson |
|
How often does the sixty minute cortisol result alter the interpretation of a short synacthen test? |
|
| Dr R John |
|
Comparison of the Bayer ADVIA Centaur BNP assay with the Roche ELECSYS pro-BNP assay |
|
| Dr R John |
|
Validation of PEG precipitation for the detection of macroprolactinaemia and quantitation of monomeric prolactin with the Bayer ADVIA Centaur assay |
|
| Dr R D Johnson |
|
A web based pathology results reporting service developed in response to direct clinical need |
|
| Miss A M Jones |
|
Evaluation of two non-radioactive microsatellite markers, 82-I and 9N-II, for the diagnosis of 21-hydroxylase deficiency |
|
| Dr R G Jones |
|
A noval approach to the delivery of Down's syndrome screening risk calculations |
|
| Dr R G Jones |
|
Medical decision support software validation: a Downs & 8217; risks calculator as an example |
|
| Dr A Kalansooriya |
|
Increased lipid peroxidation in early diabetic nephropathy |
|
| Mr J W Kane |
|
Investigations into the cause of the discrepancy in female testosterone results obtained by direct and extracted immunoassays |
|
| Mr M Kemp |
|
Hyperhomocysteinaemia may account for the excess coronary heart disease risk in UK Indian Asians compared to European whites |
|
| Mr M Kemp |
|
Plasma natriuretic peptides and left ventricular function following acute myocardial infarction |
|
| Miss M Khan |
|
Investigation of the ferrochelatase gene in 14 patients with erythropoietic protoporphyria |
|
| Dr E S Kilpatrick |
|
Can the addition interpretative comments influence outcome? an example involving patients taking thyroxine |
|
| Mrs K Kingstone |
|
Tissue transglutaminase IgA measurement in a routine laboratory: an economical approach to screening for coeliac disease |
|
| Miss S Knox |
|
DNA polymorphisms in the thiopurine S-methyl transferase gene |
|
| Mr P Koliou |
|
Effect of lipid lowering therapy on biochemical markers of bone metabolism |
|
| Dr P A Kyd |
|
A case of virilisation during pregnancy |
|
| Dr E J Lamb |
|
Topiramate increases biochemical risk of nephrolithiasis |
|
| Dr E J Lamb |
|
Estimation of glomerular filtration rate in older patients with renal insufficiency: is the MDRD formula an improvement |
|
| Mrs S A Lamph |
|
MHRA evaluation of the BRAHMS KRYPTORTM immunoassay system |
|
| Mrs S A Lamph |
|
MHRA evaluation of the Dynex Technologies DSXTM automated immunoassay |
|
| Mrs R Lapworth |
|
The effect of electronic ordering on tests of renal function |
|
| Dr G J Lawson |
|
Raised creatine kinase: "to start statin" |
|
| Dr G J Lawson |
|
Evidence of myocyte necrosis in glycogen storage disease type II (Pompe's disease) |
|
| Mrs C E Leeming |
|
Organic acid analysis by GCMS: development of a retention time locked database and automated peak identification system |
|
| Ms D Li |
|
Thyroglobulin mRNA in thyroid cancer patients |
|
| Dr C Livingstone |
|
Clinical validation of an assay for insulin-like growth factor binding protein-1 |
|
| Dr Robert Lord |
|
Acute pancreatitis severity stratification re-audit |
|
| Dr Robert Lord |
|
An audit to study the management of hyponatraemia at a District General Hospital |
|
| Dr Robert Lord |
|
Remember 'D' - teaching hyponatraemia: a personal view! |
|
| Ms H Losty |
|
Evaluation of a novel conductometric device for sweat analysis in the diagnosis of cystic fibrosis |
|
| Mr B Lynch |
|
Selenium, homocysteine and thryoid function |
|
| Mr F MacKenzie |
|
A pilot UK NEQAS scheme for thyroglobulin |
|
| Miss R Maddison |
|
Serum tartrate-resistant acid phosphatase 5b as a marker of bone metastases in prostate cancer |
|
| Miss N A Marden |
|
The use of serum anti-thyroid peroxidase antibody measurements for the management of patients with subclinical hypothyroidism in general practice |
|
| Dr S M Maxwell |
|
Maternal dietary fat intake and cord blood total cholesterol and HDL cholesterolm concentrations |
|
| Miss B Mayers |
|
Underivatised branched chain amino acid analysis in maple syrup urine disease by electrospray tandem mass spectrometry with chiral chromatography |
|
| Dr G McDowell |
|
Platelet and endothelial activation in the diagnosis of acute coronary syndromes |
|
| Dr I McFarlane |
|
Colourimetric methods for the measurement of lithium |
|
| Dr I McFarlane |
|
A new LMNA mutation associated with familial partial lipodystrophy |
|
| Mr P J McGinley |
|
Tumour markers: their use and misuse by clinicians |
|
| Dr P McKenna |
|
Are interpretative comments on clinical chemistry reports perceived by users as useful? |
|
| Miss Susan McLellan |
|
Polymorphisms in the P450 c17 and P450 c19 genes: association with sex steroids and bone mineral density in post-menopausal women |
|
| Miss F A Meakin |
|
The determination of urinary iodine by inductively coupled plasma mass spectrometry |
|
| Mrs S S Metcalfe |
|
The potential role of CA-125 as a cardiac marker in the diagnosis and monitoring of congestive heart failure |
|
| Dr J G Middle |
|
How good are we at measuring oestradiol and testosterone?: results of recent UK NEQAS ID-GCMS exercises |
|
| Dr J G Middle |
|
IFCC vs 'DCCT' calibration for HbA1c: latest data from the UK NEQAS for Glycated Haemoglobins |
|
| Dr V Mishra |
|
Normocalciuria: biochemical marker of exclusion for coeliac disease when screening patients with osteoporosis |
|
| Dr J M Monaghan |
|
Longitudinal changes of IGFs and their binding proteins throughout normal pregnancy |
|
| Dr J M Monaghan |
|
Neonatal hypocalcaemia: audit on its prevalence in a teaching hospital |
|
| Mr P Newland |
|
Evaluation an d operator dependency of four point of care devices for the measurement of haemoglobin A1c |
|
| Miss C Noyce |
|
Seminoma: will PLAP fill the gap? |
|
| Miss L S O'Shea |
|
Expression and action of calcium/calmodulin-dependent protein kinases in pituitary cell-lines and human pituitary adenomas |
|
| Mr J Overton |
|
Evaluation of latex-enhanced turbidimetric reagents for measuring free immunoglobulin light-chains on the Roche Modular P |
|
| Dr M Panarelli |
|
A case of lithium associated hyperparathyroidism |
|
| Mrs A Parasram |
|
Evaluation of pleural fluid and serum biochemical parameters in the differentiation of transudates and exudates |
|
| Miss Angela Parnham |
|
Supplementing rapid HbA1c measurements in the presence of molecular variants: total GHb meters assessed |
|
| Dr A L Patterson |
|
Metabolic autopsy: lessons from an MCAD diagnosis |
|
| Mr N Pearson |
|
Comparison of troponin T (laboratory and point of care), myoglobin and CK-MB mass in diagnosis of myocardial infarction |
|
| Dr R T Peaston |
|
Measurement of unconjugated plasma normetadrenaline and metadrenaline by immunoassay |
|
| Dr M D Penney |
|
A case of obstructive sleep apnoea: natriuresis is associated with urine urodilatin excretion rate |
|
| Mrs C J Piggott |
|
MHRA evaluation of automated pre-analytical sample processing and tracking systems |
|
| Mr L Piper |
|
The electronic delivery of patient reports to general practice |
|
| Dr M A Pollock |
|
A survey of availability of toxicological investigations in clinical biochemistry departments in Scotland |
|
| Dr M A Pollock |
|
Treatment of hyperthyroidism with herbal medicine |
|
| Mrs S P Prosser |
|
Audit of the diagnosis of diabetes in the outpatient setting |
|
| Mrs S Ram |
|
Does macroprolactin contribute to circulating prolactin in patients with multiple myeloma? |
|
| Mrs S Ram |
|
Do normoprolactinaemic samples contain macroprolactin? |
|
| Ms R L Raynor |
|
A detectable hCG |
|
| Ms R L Raynor |
|
What criteria should be used as a reflex testing strategy for multiple myeloma diagnosis using serum protein electrophoresis? |
|
| Mr Mark Redpath |
|
Plasma IL-6 and low level C-reactive protein in women with systemic lupus erythematosus and in matched controls |
|
| Mr Rowland Reece |
|
Audit of thyroid function tests elevated TSH in a GP population |
|
| Miss C A Reed |
|
An immunocytochemical investigation into the sub-cellular distribution of peroxisomal proteins in X-linked adrenoleukodystrophy |
|
| Mr C Reeves |
|
Presentation and diagnosis of a rare defect of creatine biosynthesis: guanidinoacetate methyltransferase deficiency |
|
| Dr N B Roberts |
|
How high does plasma aluminium have to go to indicate poisoning |
|
| Dr N B Roberts |
|
Simultaneous measurement of Cu, Zn and Se in physiological fluids by ICPMS |
|
| Dr B F Rocks |
|
Simultaneous measurement of methionine, homocysteine and cysteine using liquid chromatography electrospray ionisation tandem mass spectrometry |
|
| Mr A G Rumley |
|
Is homocysteine an independent risk factor for myocardial infarction?: results from the Glasgow myocardial infarction study |
|
| Dr B O Saeed |
|
Fasting homocysteine levels in adults with type 1 diabetes and retinopathy |
|
| Dr B O Saeed |
|
Plasma homocysteine concentrations in patients with type 1 diabetes |
|
| Dr R M Saldana Chaparro |
|
A reversed-phase HPLC method for plasma metadrenalines |
|
| Mr B Sampson |
|
Clinical applications of ICPMS: approaches to instrument optimisation for multi-element analysis by reaction cell ICPMS |
|
| Mr M Sargazi |
|
Biomarkers of cell damage in kidney proximal tubular cells exposed to copper |
|
| Dr N R Scott |
|
Diagnosis of type 2 diabetes mellitus: impact of a lowered threshold for performing a 75 g oral glucose tolerance test |
|
| Dr G Shabo |
|
An audit and a follow-up of Sunday morning laboratory service use |
|
| Dr G Shabo |
|
An unusual case of floating fat in urine |
|
| Dr L A Shakerdi |
|
Gas chromatography/mass spectrometry measurements of urinary mineralocorticoids as a diagnostic aid in the investigation of hypertension |
|
| Dr L Shakespeare |
|
Urinary cortisone and cortisol in obese normal subjects; reference ranges and longitudinal changes
|
|
| Dr R Sharma |
|
A case of a premature baby with hypothalamic disturbance |
|
| Dr R A Sherwood |
|
Serum Her-2/neu in prostatic disease |
|
| Dr R A Sherwood |
|
Tumour marker M2-PK in prostate disease |
|
| Mr P Showell |
|
Evaluation of latex-enhanced turbidimetric reagents for measuring free immunoglobulin light-chains on the Olympus AU400 |
|
| Mr E A Skinner |
|
Minimisation of the interference of bilirubin in the method for serum salicylate on Olympus AU640 |
|
| Dr L J Smith |
|
Sample storage and stability for free light chain assays |
|
| Miss N A Smith |
|
An improved urine protein reagent for the Olympus AU640 |
|
| Mr Ravinder Sodi |
|
A natural killer (NK)-lymphocyte based LDL receptor assay for the detection of familial hypercholesterolaemia using flow cytometry |
|
| Mrs Christine Squire |
|
Hyponatraemia following head injury |
|
| Dr R Srivastava |
|
Dumfries diazepam: the potential dangers of illicit tablets |
|
| Ms H J Stowe |
|
Serum cystatin C as a marker of renal function in multiple myeloma |
|
| Mr W Taylor |
|
Effect of micronutrient supplementation on the stress response of ecto-f' nucleotidase |
|
| Dr Y P Teoh |
|
A case of paraneoplastic creatine kinase
|
|
| Mrs L J Tetlow |
|
An evaluation of ward based glucose meters with connectivity capability in a paediatric hospital |
|
| Mr V A Tetlow |
|
GC-MS assay for buprenorphine and norbuprenorphine in urine |
|
| Mrs L K Tilbrook |
|
Audit of troponin I requesting patterns: 2 years experience of use in a district general hospital setting |
|
| Mr P M Timms |
|
Vitamin D and matrix metalloproteinase 9 in submariners |
|
| Mr J A Tovey |
|
Comparison of the Beckman Access AccuTnI and DPC Immulite Troponin I immunoassays |
|
| Mrs J M Townend |
|
Blood glucose meter EQA scheme: a review of strategies for improvement over the last 5 years |
|
| Ms A L Trewick |
|
Surveillance of External Quality Assessment of healthcare laboratories in the UK |
|
| Mrs L J Turnbull |
|
Audit of sample labelling errors |
|
| Dr P J Twomey |
|
Are triglyceride levels relevant when investgating interference due to turbidity with intralipid? |
|
| Dr P J Twomey |
|
Investigation of an objective spectrophotometric assessment of turbidity according to the European Quality requirements |
|
| Dr D J Usher |
|
Should anti-thyroid peroxidase be a laboratory-generated test in suspected subclinical hypothyroidism |
|
| Mrs J L Usher |
|
The vitamin D receptor start codon polymorphism (Fok1) and bone mineral density in patients receiving corticosteroids |
|
| Mr B Valentine |
|
Data management in multi-discipline, multi-site pathology networks |
|
| Dr D T Vallance |
|
Is reporting LDL-C in the atherogenic lipoprotein phenotype misleading? |
|
| Dr D T Vallance |
|
Is fasting plasma glucose reliable in predicting glucose tolerance in the atherogenic lipoprotein phenotype? |
|
| Dr D Van der Merwe |
|
Evaluation of sample types and stability of N-terminal proBNP in patients with heart failure |
|
| Dr C Van Heyningen |
|
Great clinical chemists from the 16th to the 20th century |
|
| Miss H Varney |
|
Electrospray ionisation tandem mass spectrometric assay of 6-methylmercaptopurine as a measure of thiopurine methyl-transfersase activity |
|
| Miss J M Walker |
|
A case of acute intermittent porphyria and pseudophaeochromocytoma |
|
| Mrs C Wands |
|
The development of serum free light chain immunoassay on Bayer Advia 1650 |
|
| Dr Ian Watson |
|
Audit and re-audit of hyponatraemia in total join arthroplasty |
|
| Dr P R Wenham |
|
Oxyhaemoglobin interferes with the determination of the net bilirubin absorbance in CSF |
|
| Mr Peter West |
|
An audit of requests for serum protein electrophoresis in a district general hospital |
|
| Mr Peter West |
|
An interesting case of a neonate presenting with trisomy 13 (Patau's Syndrome), glucose 6 phosphate dehydrogenase deficiency and hypothyroidism |
|
| Mr S J Whiting |
|
Plasma acetyl L-carnitine and L-carnitine concentrations in HIV-1 infected individuals following acetyl L-carnitine supplementation |
|
| Mr S J Whiting |
|
Comparison of plasma acetyl L-carnitine concentrations in HIV-1 infected individuals given acetyl L-carnitine supplements in either single or divided doses |
|
| Dr D Wickens |
|
Multiple myeloma masquerading as tuberculosis |
|
| Dr R L Wilmot |
|
That sickening feeling, cause or effect?: two cases of hypercalcaemia presenting in pregnancy |
|
| Dr W W Woltersdorf |
|
Late onset primary hypoparathyroidism |
|
| Dr W W Woltersdorf |
|
Refeeding syndrome: an effective and sfae protocol for treatment of hypophosphataemia |
|
| Dr P J Wood |
|
A case of "permanent MI": doubling dilutions fail as a check for antibody interference in immunometric assays |
|
| Miss H Y Wu |
|
Cystine and dibasic amino acids analysis by electrospray tandem mass-spectrometry of underivatised samples: a rapid method for cystinuria screening and monitoring |
|
| |